Illinois, USA-based Assertio Holdings yesterday announced a definitive agreement to be acquired by Garda Therapeutics for $18 ...
The US Centers for Medicare & Medicaid Services (CMS) is preparing states for an upcoming change that will limit the ability ...
Jeito Capital, a Paris, France -based independent private equity fund dedicated to Biopharma, has announced the final closing ...
Late last year, Julie Dehaene-Puype stepped into the role of Regional President at Kyowa Kirin International (KKI), a ...
Boston, USA-based Cue Biopharma announced that it will receive a $7.5 million pre-clinical milestone payment under its ...
The US Food and Drug Administration (FDA) has outlined a number of legislative proposals in its fiscal 2027 budget request.
Chinese nuclear medicine company New Radiomedicine Technology (NRT) has raised more than 1 billion yuan ($145.3 million) in a ...
Rare disease drug pricing has long rested on a simple trade-off. Small patient populations and high development costs ...
Privately-held Alloy Therapeutics, a biotech ecosystem company promising to democratize access to new drug discovery ...
Boston, USA-based biotech Life Biosciences, which is pioneering cellular rejuvenation therapies to reverse and prevent ...
German drug developer Evotec (FRANKFURT: EVT) reported fourth-quarter 2025 revenue of $293 million, up 14%, and adjusted ...
Colorado, USA-based biotech Renovare Therapeutics, which is pioneering regenerative therapeutics for osteoarthritis, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results